机器人辅助经颅多普勒与经胸超声心动图检测右向左分流对比
这项前瞻性单臂器械临床试验在6个临床中心纳入154例疑似栓塞性脑血管缺血患者,比较机器人辅助经颅多普勒(raTCD)与经胸超声心动图(TTE)检测右向左分流(RLS)的检出率。可评估129例中,raTCD阳性82例(64%),TTE阳性26例(20%),绝对差异43.4%(95%CI 35.2%-52.0%,P<0.001);raTCD检出大分流35例(27%),TTE检出13例(10%),绝对差异17.0%(95%CI 11.5%-24.5%,P<0.001)。raTCD安全,未发生严重不良事件。
要点
- raTCD检出RLS 64%,TTE检出20%,绝对差异43.4%(95%CI 35.2%-52.0%,P<0.001)。
- raTCD检出大分流27%,TTE检出10%,绝对差异17.0%(95%CI 11.5%-24.5%,P<0.001)。
- raTCD未发生严重不良事件,TTE完全漏诊或低估了raTCD诊断的大分流的三分之二。
核心结论
- raTCD安全,诊断RLS的可能性约为TTE的3倍;TTE完全漏诊或低估了raTCD诊断的大分流的三分之二。
- 在确认性研究完成前,经颅多普勒(TCD)似乎比TTE更适合作为RLS的筛查方法。
研究设计与样本
- 前瞻性、单臂器械临床试验,在6个临床中心纳入2020年10月6日至2021年10月20日期间出现疑似栓塞性脑血管缺血事件的患者。
- 共纳入154例患者,可评估129例(意向扫描),121例按方案完成完整数据。
- raTCD采用标准TCD气泡试验技术,TTE气泡试验按当地标准执行。
- 主要结局为raTCD与TTE的RLS检出率。
主要发现
- 意向扫描队列平均年龄60±15岁,47%为女性,所有合格事件均诊断为缺血性卒中或短暂性脑缺血发作。
- raTCD阳性82例(64%),TTE阳性26例(20%),绝对差异43.4%(95%CI 35.2%-52.0%),P<0.001。
- 预设次要分析中,raTCD检出大分流35例(27%),TTE检出13例(10%),绝对差异17.0%(95%CI 11.5%-24.5%),P<0.001。
- 未发生严重不良事件。
临床怎么用
- raTCD设备由无TCD培训经验的医疗专业人员操作,可能使提供者在无需经验丰富操作者执行测试的情况下,达到TCD检测RLS和卵圆孔未闭的已知灵敏度。
- 在确认性研究完成前,TCD似乎比TTE更适合作为RLS的筛查方法。
局限性
- 在确认性研究完成前,TCD似乎比TTE更适合作为RLS的筛查方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Right to left shunt (RLS), including patent foramen ovale, is a recognized risk factor for stroke. RLS/patent foramen ovale diagnosis is made by transthoracic echocardiography (TTE), which is insensitive, transesophageal echocardiography, which is invasive, and transcranial Doppler (TCD), which is noninvasive and accurate but scarce. METHODS: We conducted a prospective, single-arm device clinical trial of robot-assisted TCD (raTCD) versus TTE for RLS diagnosis at 6 clinical sites in patients who presented with an event suspicious for embolic cerebrovascular ischemia from October 6, 2020 to October 20, 2021. raTCD was performed with standard TCD bubble study technique. TTE bubble study was performed per local standards. The primary outcome was rate of RLS detection by raTCD versus TTE. RESULTS: A total of 154 patients were enrolled, 129 evaluable (intent to scan) and 121 subjects had complete data per protocol. In the intent to scan cohort, mean age was 60±15 years, 47% were women, and all qualifying events were diagnosed as ischemic stroke or transient ischemic attack. raTCD was positive for RLS in 82 subjects (64%) and TTE was positive in 26 (20%; absolute difference 43.4% [95% CI, 35.2%-52.0%]; P<0.001). On prespecified secondary analysis, large RLS was detected by raTCD in 35 subjects (27%) versus 13 (10%) by TTE (absolute difference 17.0% [95% CI, 11.5%-24.5%]; P<0.001). There were no serious adverse events. CONCLUSIONS: raTCD was safe and ≈3 times more likely to diagnose RLS than TTE. TTE completely missed or underdiagnosed two thirds of large shunts diagnosed by raTCD. The raTCD device, used by health professionals with no prior TCD training, may allow providers to achieve the known sensitivity of TCD for RLS and patent foramen ovale detection without the need for an experienced operator to perform the test. Pending confirmatory studies, TCD appears to be the superior screen for RLS compared with TTE (funded by NeuraSignal). REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT04604015.
引用
- Rubin MN, Shah R, Devlin T, et al. Robot-Assisted Transcranial Doppler Versus Transthoracic Echocardiography for Right to Left Shunt Detection. Stroke. 2023. PMID: 37795589. doi:10.1161/STROKEAHA.123.043380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。